Drugs and Toxins Affecting Liver Vessels

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Vascular Disorders of the Liver

• Publication date

  2021-12-04

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/978-3-030-82988-9_21
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• EASL Clinical Practice Guidelines: Drug-induced liver injury.

  2019cited by this paper
• Drug induced liver injury with analysis of alternative causes as confounding variables

  2018cited by this paper
• Reversibility of chemotherapy-related liver injury.

  2017cited by this paper
• Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)

  2017cited by this paper
• EASL Clinical Practice Guidelines: Vascular diseases of the liver.

  2016cited by this paper
• Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome

  2016cited by this paper
• EFSA (European Food Safety Authority), 2016. Dietary exposure assessment to pyrrolizidine alkaloids in the European population

  2016cited by this paper
• Nodular Regenerative Hyperplasia in Patients Undergoing Liver Resection for Colorectal Metastases After Chemotherapy: Risk Factors, Preoperative Assessment and Clinical Impact

  2015cited by this paper
• The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome

  2015cited by this paper
• Human immunodeficiency virus and nodular regenerative hyperplasia of liver: A systematic review.

  2014cited by this paper
• Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model

  2013cited by this paper
• Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis

  2013cited by this paper
• Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

  2013cited by this paper
• Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy

  2013cited by this paper
• Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases

  2012cited by this paper
• Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis

  2012cited by this paper
• A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity

  2012cited by this paper
• Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.

  2012cited by this paper
• Splenomegaly in FOLFOX-naïve stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy

  2011cited by this paper
• Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine

  2011cited by this paper
• The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.

  2011cited by this paper
• Herbal medicine hepatotoxicity: a new step with development of specific biomarkers.

  2011cited by this paper
• Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.

  2011cited by this paper
• The epidemiology and clinical features of portal vein thrombosis: a multicentre study

  2010cited by this paper
• Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study

  2010cited by this paper
• Regenerative Nodular Hyperplasia of the Liver Related to Chemotherapy: Impact on Outcome of Liver Surgery for Colorectal Metastases

  2010cited by this paper
• Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin‐associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis

  2010cited by this paper
• Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

  2009cited by this paper
• Vinyl chloride and the liver.

  2009cited by this paper
• Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II–III Colorectal Cancer

  2009cited by this paper
• Etiology, management, and outcome of the Budd-Chiari syndrome.

  2009cited by this paper
• The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

  2009cited by this paper
• Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

  2008cited by this paper
• Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia

  2008cited by this paper
• 6-Thioguanine Associated Nodular Regenerative Hyperplasia in Patients With Inflammatory Bowel Disease May Induce Portal Hypertension

  2007cited by this paper
• Prognostic Factors in Noncirrhotic Patients With Splanchnic Vein Thromboses

  2007cited by this paper
• Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

  2007cited by this paper
• Drug‐induced liver injury at an Asian center: a prospective study

  2007cited by this paper
• Hypervitaminosis A‐induced liver fibrosis: stellate cell activation and daily dose consumption

  2006cited by this paper
• Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.

  2006cited by this paper
• Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome

  2006cited by this paper
• Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

  2006cited by this paper
• The acute and chronic toxic effects of vitamin A.

  2006cited by this paper
• Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis

  2005cited by this paper
• Increased Risk of Hepatocellular Carcinoma and Liver Cirrhosis in Vinyl Chloride Workers: Synergistic Effect of Occupational Exposure with Alcohol Intake

  2004cited by this paper
• Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

  2004cited by this paper
• Incidence of drug‐induced hepatic injuries: A French population‐based study

  2002cited by this paper
• Extrahepatic portal vein thrombosis: aetiology and determinants of survival

  2001cited by this paper
• Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors

  2000cited by this paper
• Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease

  1996cited by this paper
• Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

  1993cited by this paper
• Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases.

  1991cited by this paper
• Azathioprine hepatotoxicity after liver transplantation

  1991cited by this paper
• Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.

  1991cited by this paper
• Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis.

  1989cited by this paper
• Peliosis hepatis induced by 6-thioguanine administration.

  1988cited by this paper
• Azathioprine and hepatic venocclusive disease in renal transplant patients.

  1986cited by this paper
• Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: A case-control study

  1986cited by this paper
• Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.

  1986cited by this paper
• Early Hepatic Histologic Alterations Among Chemical (Vinyl Monomer) Workers

  1984cited by this paper
• Hepatic veno-occlusive disease caused by 6-thioguanine.

  1982cited by this paper
• Reversible hepatic veno-occlusive disease and 6-thioguanine.

  1982cited by this paper
• Hepatic Lesions Caused by Anabolic and Contraceptive Steroids 1

  1981cited by this paper
• Is renal transplantation involved in post-transplantation liver disease? A prospective study.

  1980cited by this paper
• Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.

  1979cited by this paper
• Peliosis hepatis in recipients of renal transplants.

  1978cited by this paper

• No citing papers are available for this paper.